GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam". It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Vietnam, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.
In 2013, Vietnam's population stood at 89.7 million, an increase from 85.1 million in 2008 due to the high birth rate and low mortality rate. The country's pharmaceutical market was estimated to have been worth $2.9 billion in 2013 and is expected to reach $8 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 15.4%. According to an EU Economic and Commercial Counsellor (EUECC) report in 2011, Vietnam's medical device market was estimated at approximately $220m in 2010 and is expected to grow at a CAGR of 10% to over $350m by 2015.
The positive trends in Vietnam's healthcare market can primarily be attributed to -
This report provides information on the healthcare, regulatory, and reimbursement landscape in the Vietnam, including the following -
The report will enhance your decision-making capability by allowing you to -
Browse more Drug Regulation Market Research Reports